Neurana Pharmaceuticals Announces Publication of Driving Study SAN DIEGO, Calif., May 12, 2020 – Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced the publication of a driving...
Kit Check Announces New Sanitization Feature and Medication Tagging Milestone Company’s RFID solution, now with Sanitization Check feature to better support COVID-19 frontline providers, reaches 100 million medications tagged WASHINGTON (May 4, 2020) — Kit Check™, the...
Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020 — Financing Led by Pivotal bioVenture Partners — Company Announces Lead Product Candidate for the Prevention of a Potentially...
BrightInsight and CSL Behring Announce Global Digital Health Partnership to Improve Treatment Experience for Patients with Rare Diseases CSL Behring selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant...
HARPOON THERAPEUTICS DOSES FIRST PATIENT WITH HPN217, A BCMA TARGETING TRITAC, FOR MULTIPLE MYELOMA Initiation of the clinical trial triggers $50 million milestone payment from AbbVie SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Harpoon...
TigerConnect Launches TigerTouch Video and Voice Telehealth Features to Help Hospitals Combat COVID-19 TigerTouch simplifies telehealth for patients with video, voice, and text messaging in a single smartphone-friendly user experience SANTA MONICA, California — April...
Recent Comments